|
[1]
|
Fabian, I.D., Onadim, Z., Karaa, E., Duncan, C., Chowdhury, T., Scheimberg, I., et al. (2018) The Management of Retinoblastoma. Oncogene, 37, 1551-1560. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Aerts, I., Lumbroso-Le Rouic, L., Gauthier-Villars, M., Brisse, H., Doz, F. and Desjardins, L. (2006) Retinoblastoma. Orphanet Journal of Rare Diseases, 1, Article No. 31. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Fabian, I.D. and Sagoo, M.S. (2018) Understanding Retinoblastoma: Epidemiology and Genetics. Community Eye Health, 31, 7.
|
|
[4]
|
Shields, C., Ancona-Lezama, D. and Dalvin, L. (2020) Modern Treatment of Retinoblastoma: A 2020 Review. Indian Journal of Ophthalmology, 68, 2356-2365. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Jiménez, I., Laé, M., Tanguy, M., Savignoni, A., Gauthier‐Villars, M., Desjardins, L., et al. (2020) Craniofacial Second Primary Tumors in Patients with Germline Retinoblastoma Previously Treated with External Beam Radiotherapy: A Retrospective Institutional Analysis. Pediatric Blood & Cancer, 67, e28158. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Walk, E.E., Yohe, S.L., Beckman, A., Schade, A., Zutter, M.M., Pfeifer, J., et al. (2019) The Cancer Immunotherapy Biomarker Testing Landscape. Archives of Pathology & Laboratory Medicine, 144, 706-724. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Gottfried, E., Kreutz, M. and Mackensen, A. (2012) Tumor Metabolism as Modulator of Immune Response and Tumor Progression. Seminars in Cancer Biology, 22, 335-341. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Bezzi, M., Seitzer, N., Ishikawa, T., Reschke, M., Chen, M., Wang, G., et al. (2018) Diverse Genetic-Driven Immune Landscapes Dictate Tumor Progression through Distinct Mechanisms. Nature Medicine, 24, 165-175. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Chew, V., Toh, H.C. and Abastado, J. (2012) Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy. Journal of Oncology, 2012, Article ID: 608406. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Saito, R., Abe, H., Kunita, A., Yamashita, H., Seto, Y. and Fukayama, M. (2017) Overexpression and Gene Amplification of PD-L1 in Cancer Cells and PD-L1+ Immune Cells in Epstein-Barr Virus-Associated Gastric Cancer: The Prognostic Implications. Modern Pathology, 30, 427-439. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Pagès, F., Galon, J., Dieu-Nosjean, M., Tartour, E., Sautès-Fridman, C. and Fridman, W. (2009) Immune Infiltration in Human Tumors: A Prognostic Factor That Should Not Be Ignored. Oncogene, 29, 1093-1102. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Singh, L., Singh, M.K., Rizvi, M.A., Bakhshi, S., Meel, R., Lomi, N., et al. (2020) Clinical Relevance of the Comparative Expression of Immune Checkpoint Markers with the Clinicopathological Findings in Patients with Primary and Chemoreduced Retinoblastoma. Cancer Immunology, Immunotherapy, 69, 1087-1099. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Schefler, A.C. and Kim, R.S. (2021) Recent Advancements in the Management of Retinoblastoma and Uveal Melanoma. Faculty Reviews, 10, Article 51. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
许宗仁, 廖星芸, 侯胜平. 视网膜母细胞瘤免疫细胞特征及关键基因的识别[J]. 免疫学杂志, 2021, 37(5): 410-416.
|
|
[15]
|
Newman, A.M., Liu, C.L., Green, M.R., Gentles, A.J., Feng, W., Xu, Y., et al. (2015) Robust Enumeration of Cell Subsets from Tissue Expression Profiles. Nature Methods, 12, 453-457. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Fridman, W.H., Pagès, F., Sautès-Fridman, C. and Galon, J. (2012) The Immune Contexture in Human Tumours: Impact on Clinical Outcome. Nature Reviews Cancer, 12, 298-306. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Komohara, Y., Fujiwara, Y., Ohnishi, K. and Takeya, M. (2016) Tumor-Associated Macrophages: Potential Therapeutic Targets for Anti-Cancer Therapy. Advanced Drug Delivery Reviews, 99, 180-185. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L. and Allavena, P. (2017) Tumour-Associated Macrophages as Treatment Targets in Oncology. Nature Reviews Clinical Oncology, 14, 399-416. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Sakaguchi, S., Yamaguchi, T., Nomura, T. and Ono, M. (2008) Regulatory T Cells and Immune Tolerance. Cell, 133, 775-787. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Vivier, E., Tomasello, E., Baratin, M., Walzer, T. and Ugolini, S. (2008) Functions of Natural Killer Cells. Nature Immunology, 9, 503-510. [Google Scholar] [CrossRef] [PubMed]
|